Founders Capital Management Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Founders Capital Management reduced its stake in Stryker Corporation by 3.52% during the most recent quarter end. The investment management company now holds a total of 30,367 shares of Stryker Corporation which is valued at $3.3 Million after selling 1,107 shares in Stryker Corporation according to a report filed by the company on Apr 5, 2016 with the SEC.Stryker Corporation makes up approximately 1.92% of Founders Capital Management’s portfolio.

Other Hedge Funds, Including , Private Asset Management Inc reduced its stake in SYK by selling 700 shares or 7.56% in the most recent quarter. The Hedge Fund company now holds 8,560 shares of SYK which is valued at $926,620. Stryker Corporation makes up approx 0.17% of Private Asset Management Inc’s portfolio.Lvm Capital Management Ltdmi reduced its stake in SYK by selling 3,075 shares or 9.87% in the most recent quarter. The Hedge Fund company now holds 28,075 shares of SYK which is valued at $3 Million. Stryker Corporation makes up approx 0.97% of Lvm Capital Management Ltdmi’s portfolio.Pensionfund Sabic reduced its stake in SYK by selling 2,800 shares or 14.0% in the most recent quarter. The Hedge Fund company now holds 17,200 shares of SYK which is valued at $1.9 Million. Stryker Corporation makes up approx 0.57% of Pensionfund Sabic’s portfolio.Beacon Financial Group reduced its stake in SYK by selling 15 shares or 0.44% in the most recent quarter. The Hedge Fund company now holds 3,381 shares of SYK which is valued at $366,906. Stryker Corporation makes up approx 0.08% of Beacon Financial Group’s portfolio.

On the company’s financial health, Stryker Corporation reported $1.56 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jan 26, 2016. Analyst had a consensus of $1.55. The company had revenue of $2715.00 million for the quarter, compared to analysts expectations of $2714.84 million. The company’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.44 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .Barclays Resumed Stryker Corporation on Apr 11, 2016 to “Underweight”, Price Target of the shares are set at $107.Stryker Corporation was Initiated by Nomura to “Neutral” on Mar 17, 2016.

Stryker Corporation closed down -0.29 points or -0.27% at $108.25 with 19,12,587 shares getting traded on Monday. Post opening the session at $108.49, the shares hit an intraday low of $108.17 and an intraday high of $108.94 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.